Anthem Biosciences shares listed on the stock exchanges on Monday with a premium of about 27 percent over it's initial public offer (IPO) price. The Rs 3,395-crore public offer was priced in the band of Rs 540-570 per share, and received strong investor interest with about 64 times subscription during the offer period from July 14 to 16.